Biomarkers for endometriosis : state of the art /: state of the art. (2017)
- Record Type:
- Book
- Title:
- Biomarkers for endometriosis : state of the art /: state of the art. (2017)
- Main Title:
- Biomarkers for endometriosis : state of the art
- Further Information:
- Note: Thomas D'Hooghe, editor.
- Other Names:
- D'Hooghe, Thomas
- Contents:
- Biomarkers and Endometriosis: The Needto Move Beyond Innovation to Validation; Contents; Contributors; Building Translational Research Infrastructure and Access to Expertise for Biomarker Discovery in Cancer; Introduction; Personalised Medicine and the Use of Biomarkers; The Need for Translational Research Infrastructure; Key Elements of Translational Research Infrastructure and Accessing Expertise; Clinical Use; Management of the Biosample Life Cycle; Quality of Biosamples and the Associated Data; Selection of Collected Biosamples; Accessibility of Biosamples. Future Use of Biosamples Clinical Phenotyping; Biomarker Analysis; A Variety of High-Throughput Platforms for Molecular Analysis; Assay Robustness, Reproducibility and Analytical Validation; Clinical Validity and Clinical Utility; Data Management; Clinical Data; Biosample Metadata; Molecular Data; Interoperable Databases and Information Technology; Data Analysis; Biostatistics; Bioinformatics and System Biology; Verifying Quality and Expertise, Quality Assurance and Quality Control; Quality Assurance of Laboratory Testing; Quality Assurance in Biobanking. Logistics and Operational Support Governance; Ethical Principles for the Use of Biosamples in Research; Use and Reuse of Data in Biomarker Research; Future Trends: New Ways of Working; Industry-Academia Partnerships; Open Innovation Applied to Biomarker Signature Discovery; Collaborative Platforms for Harmonisation and Exchange; Recognising the Benefits of Sharing;Biomarkers and Endometriosis: The Needto Move Beyond Innovation to Validation; Contents; Contributors; Building Translational Research Infrastructure and Access to Expertise for Biomarker Discovery in Cancer; Introduction; Personalised Medicine and the Use of Biomarkers; The Need for Translational Research Infrastructure; Key Elements of Translational Research Infrastructure and Accessing Expertise; Clinical Use; Management of the Biosample Life Cycle; Quality of Biosamples and the Associated Data; Selection of Collected Biosamples; Accessibility of Biosamples. Future Use of Biosamples Clinical Phenotyping; Biomarker Analysis; A Variety of High-Throughput Platforms for Molecular Analysis; Assay Robustness, Reproducibility and Analytical Validation; Clinical Validity and Clinical Utility; Data Management; Clinical Data; Biosample Metadata; Molecular Data; Interoperable Databases and Information Technology; Data Analysis; Biostatistics; Bioinformatics and System Biology; Verifying Quality and Expertise, Quality Assurance and Quality Control; Quality Assurance of Laboratory Testing; Quality Assurance in Biobanking. Logistics and Operational Support Governance; Ethical Principles for the Use of Biosamples in Research; Use and Reuse of Data in Biomarker Research; Future Trends: New Ways of Working; Industry-Academia Partnerships; Open Innovation Applied to Biomarker Signature Discovery; Collaborative Platforms for Harmonisation and Exchange; Recognising the Benefits of Sharing; Conclusions; References; Biomarkers of Endometrial Cancer; Introduction; Epidemiology; Aetiology and Risk Factors; The Dualistic Model; Clinical Presentation; Investigations; Transvaginal Ultrasound. Hysteroscopy and Endometrial BiopsyStaging; Treatment; Molecular Biology and Genetics of EC; Type 1 (Endometrioid) EC; Type 2 (Serous and Clear Cell) EC; Diagnostic/Screening Markers; Prognostic/Staging Biomarkers; Tissue Biomarkers; Serum Biomarkers; Conclusions and Future Approaches; References; Biomarker Development in Chronic Inflammatory Diseases; Introduction; Biomarkers in Inflammatory Bowel Diseases; Serological Biomarkers of Acute Phase Response; C-reactive Protein; Erythrocyte Sedimentation Rate; Platelets; Serological Markers with Restricted Clinical Use in IBD. Orosomucoid Anti-Saccharomyces cerevisiae Antibodies; Anti-neutrophil Cytoplasmic Antibodies; Anti-glycan Antibodies; Antibody to Outer Membrane Porin (Anti-OmpC); Anti-flagellin Antibodies; Anti-Cbir1; Antibody to Pseudomonas fluorescens: Associated Sequence I2 (Anti-I2); Antibodies to Flagellins A4-Fla2 and Fla-X; Emerging Serological Markers in IBD: Cytokines; Interleukins; TNF-a and TNFa Receptors; Fecal Biomarkers in IBD; Fecal Calprotectin; Fecal Lactoferrin; Biomarkers in Chronic Inflammatory Diseases of Hepatology. … (more)
- Publisher Details:
- Cham : Springer
- Publication Date:
- 2017
- Extent:
- 1 online resource
- Subjects:
- 618.1/075
Medicine
Endometriosis -- Diagnosis
Biochemical markers
MEDICAL -- Gynecology & Obstetrics
Biochemical markers
Medicine & Public Health
Reproductive Medicine
Bioinformatics
Human Genetics
Endometriosis -- diagnosis
Biomarkers
Science -- Life Sciences -- Anatomy & Physiology
Medical -- Genetics
Molecular biology
Medical genetics
Reproductive Medicine
Bioinformatics
Human genetics
Health & Fitness -- Diseases -- Genetic
Reproductive medicine
Electronic books
Electronic book - Languages:
- English
- ISBNs:
- 9783319598567
3319598562 - Related ISBNs:
- 9783319598543
3319598546 - Notes:
- Note: Includes bibliographical references and index.
Note: Print version record. - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.370702
- Ingest File:
- 01_355.xml